Background: Cases of discordant responses in multiple myeloma ( MM) patients after thalidomide therapy have been sometimes reported, in which extramedullary masses progress or present de novo with a simultaneous serum monoclonal protein reduction. Patients and Methods: We hereby report, for the first time, on two cases of MM patients with extramedullary myeloma localizations that developed during Velcade (bortezomib, PS341) treatment with a concomitant serum monoclonal protein reduction. Results: We observed in both patients a very good response in the serum monoclonal protein level, while extramedullary lesions appeared in the central nervous system and subcutaneously. Conclusions: We discuss pharmacokinetics of bortezomib and physiopathology of this unusual event and review the literature.

Pirrotta, M.T., Gozzetti, A., Cerase, A., Bucalossi, A., Bocchia, M., Defina, M., et al. (2008). Unusual discordant responses in two multiple myeloma patients during bortezomib treatment. ONKOLOGIE, 31(1-2), 45-47 [10.1159/000112217].

Unusual discordant responses in two multiple myeloma patients during bortezomib treatment

Gozzetti A.;Bocchia M.;
2008-01-01

Abstract

Background: Cases of discordant responses in multiple myeloma ( MM) patients after thalidomide therapy have been sometimes reported, in which extramedullary masses progress or present de novo with a simultaneous serum monoclonal protein reduction. Patients and Methods: We hereby report, for the first time, on two cases of MM patients with extramedullary myeloma localizations that developed during Velcade (bortezomib, PS341) treatment with a concomitant serum monoclonal protein reduction. Results: We observed in both patients a very good response in the serum monoclonal protein level, while extramedullary lesions appeared in the central nervous system and subcutaneously. Conclusions: We discuss pharmacokinetics of bortezomib and physiopathology of this unusual event and review the literature.
2008
Pirrotta, M.T., Gozzetti, A., Cerase, A., Bucalossi, A., Bocchia, M., Defina, M., et al. (2008). Unusual discordant responses in two multiple myeloma patients during bortezomib treatment. ONKOLOGIE, 31(1-2), 45-47 [10.1159/000112217].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/2596
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo